CONCLUSIONS: This study demonstrates the feasibility of the proposed trial method and provides insight into likely effect sizes for the design of further studies. The measured learning outcomes were similar across the groups, regardless of which simulation modalities were used prior to assessment. Our study found no statistically significant differences for VR simulation versus IP… →

CONCLUSION: Perioperative systemic lidocaine infusion in patients with breast cancer could modulate the production of IL-6, and through the reduction of this cytokine, patients experienced better pain control in the immediate postoperative period. →

CONCLUSION: Efgartigimod demonstrated comparable efficacy to IVIg for IMC remission but with a significantly faster onset, supporting its role as a rapid and safe alternative. →

CONCLUSION: Short-term treatment with low-dose escitalopram significantly alleviates depression and anxiety in COPD patients. Notably, this brief intervention initiated a sustained positive clinical trajectory over 12 months. Combined with a favorable safety profile, these findings support its potential integration into comprehensive COPD management protocols, pending multicenter validation. →

CONCLUSION: The combination of remimazolam reduced the incidence of cough reflexes and dosage of cipepofol and remifentanil in elderly patients undergoing FOB under remifentanil/cipepofol-based anaesthesia. →

OpenCV is continuing our partnership with the awesome Display Week conference, joining them in Los Angeles this May 4th for a special one-day event packed with insights from Computer Vision & AI visionaries and a 3-hour workshop from OpenCV CEO Dr. Satya Mallick. OSCCA is back for 2026! Last year was the first time we’d… →
Most early-stage founders know their product better than anyone alive. But selling is a different nuanced beast. We recently hosted a private workshop on founder-led sales for 20 founders, and the feedback was incredible. We partnered with Pete Kazanjy on the event – author of Founding Sales, co-founder of TalentBin (acquired by Monster), Atrium, and… →
CONCLUSIONS: Overall, short-term AKB supplementation was associated with modest, exploratory changes in selected functional and systemic biomarker outcomes, but larger and longer-term studies are needed to confirm clinical relevance and clarify underlying mechanisms. →
